Compassionate Use of Eribulin for the Treatment of Advanced Breast Cancer Refractory to All Other Marketed Therapies
Clinical trial NCT01142661 · COMPLETED
Trial details
- NCT number
- NCT01142661
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2011-08-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.